UNSPSC 85811529: Introduction of other antineoplastic into pleural cavity, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other antineoplastic into pleural cavity, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0L305

UNSPSC 85811529 Introduction of other antineoplastic into pleural cavity, percutaneous approach is a Commodity code that does not align with recent state and local procurement activity captured in the source. The code describes a specific medical procedure—chemotherapy administration into the pleural cavity via percutaneous needle insertion—yet the 40 recent opportunities tagged under this code span virtual urgent care, occupational health screenings, cancer registry services, opioid treatment and recovery programs, youth crisis stabilization, employee wellness platforms, EMS revenue billing, nursing home operations, psychological evaluations, and emergency medical direction. These solicitations address administrative healthcare management, behavioral health delivery, and occupational wellness rather than oncology procedure services or any related work at the procedure level.

The issuing bodies span state health departments, county governments, cities, independent school districts, transit authorities, health systems, and municipal agencies across California, Georgia, Nevada, Colorado, Florida, Arizona, Texas, Kansas, and other states. No pattern of repeat buyers or geographic concentration emerges from the opportunities. The code shows no relevant recent activity in state and local procurement; the tagging appears to reflect a misclassification or system error rather than genuine procurement demand for pleural chemotherapy administration services at the state and local level.